Greater angiogenic and immunoregulatory potency of bfgf and 5-aza-2ʹ-deoxycytidine pre-treated menstrual blood stem cells in compare to bone marrow stem cells in rat model of myocardial infarction

HIGHLIGHTS

• who: Mahmood Manshori from the Tehran, Iran Physiology Research Center, Iran University of Medical Sciences, Tehran have published the research work: Greater angiogenic and immunoregulatory potency of bFGF and 5-aza-2u02b9-deoxycytidine pre-treated menstrual blood stem cells in compare to bone marrow stem cells in rat model of myocardial infarction, in the Journal: (JOURNAL)
• what: Background: This study is designed to compare the menstrual blood stem cells (MenSCs) and bone marrow stem cells (BMSCs)-secreted factors with or without pre-treatment regimen using basic fibroblast growth factor (bFGF) and 5-aza-2u02b9-deoxycytidine . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.